The so-called Netflix payment model for obtaining hepatitis C treatments appears to be catching on among state officials as a Washington state health agency is the latest one hoping to convince drug makers to participate in such a scheme.
The state Health Care Authority late last month began soliciting bids from drug makers to provide a guaranteed net unit price for Medicaid beneficiaries, and a similarly low price for other state employees. The goal is to eradicate the chronic disease from these groups by 2030 and to lower spending that last year reached about $80 million.
About the Author Reprints
